4//SEC Filing
Miller James Charles 4
Accession 0001192482-21-000159
CIK 0001588972other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:49 PM ET
Size
5.0 KB
Accession
0001192482-21-000159
Insider Transaction Report
Form 4
Miller James Charles
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-02-09+20,000→ 20,000 totalExercise: $4.06Exp: 2031-02-09→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal installments on February 9, 2022, 2023 and 2024.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001846245
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:49 PM ET
- Size
- 5.0 KB